Skip to Content

We invite you to try out our new beta eCFR site at https://webarchive.library.unt.edu/web/20201219111750/https://ecfr.federalregister.gov. We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DD21-001, Study To Explore Early Development (SEED) Follow Up Studies; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Centers for Disease Control and Prevention (CDC), Health and Human Services.

ACTION:

Notice; correction.

SUMMARY:

The CDC published a document in the Federal Register of September 30, 2020, concerning a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DD21-001, Study to Explore Early Development (SEED) Follow up Studies. The document contained incorrect dates.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop S107-8, Atlanta, Georgia 30341, Telephone: (770) 488-6511, JRaman@cdc.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Correction

In the Federal Register of September 30, 2020, in FR Doc 2020-21604, on page 61752, in the first column, correct the “Date” and “Time” captions to read:

Date: January 12, 2021.

Time: 10:00 a.m.-6:00 p.m., EST.

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Kalwant Smagh,

Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

End Signature End Supplemental Information

[FR Doc. 2020-25959 Filed 11-23-20; 8:45 am]

BILLING CODE 4163-18-P